Groner B - Search Results

1

Schnierle BS, Groner B. Schnierle BS, et al. Among authors: groner b. Gene Ther. 1996 Dec;3(12):1069-73. Gene Ther. 1996. PMID: 8986432 Review.

2

Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles.

Schnierle BS, Moritz D, Jeschke M, Groner B. Schnierle BS, et al. Among authors: groner b. Gene Ther. 1996 Apr;3(4):334-42. Gene Ther. 1996. PMID: 8732165

3

Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells.

Schnierle BS, Stitz J, Bosch V, Nocken F, Merget-Millitzer H, Engelstädter M, Kurth R, Groner B, Cichutek K. Schnierle BS, et al. Among authors: groner b. Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8640-5. doi: 10.1073/pnas.94.16.8640. Proc Natl Acad Sci U S A. 1997. PMID: 9238030 Free PMC article.

4

Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytes.

Altenschmidt U, Kahl R, Moritz D, Schnierle BS, Gerstmayer B, Wels W, Groner B. Altenschmidt U, et al. Among authors: groner b. Clin Cancer Res. 1996 Jun;2(6):1001-8. Clin Cancer Res. 1996. PMID: 9816261

5

Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles.

Höhne M, Thaler S, Dudda JC, Groner B, Schnierle BS. Höhne M, et al. Among authors: groner b. Virology. 1999 Aug 15;261(1):70-8. doi: 10.1006/viro.1999.9847. Virology. 1999. PMID: 10441556 Free article.

6

Stable expression of the ecotropic retrovirus receptor in amphotropic packaging cells facilitates the transfer of recombinant vectors and enhances the yield of retroviral particles.

Gerstmayer B, Groner B, Wels W, Schnierle BS. Gerstmayer B, et al. Among authors: groner b. J Virol Methods. 1999 Aug;81(1-2):71-5. doi: 10.1016/s0166-0934(99)00053-1. J Virol Methods. 1999. PMID: 10488763

7

Biotechnological and gene therapeutic strategies in cancer treatment.

Wels W, Moritz D, Schmidt M, Jeschke M, Hynes NE, Groner B. Wels W, et al. Among authors: groner b. Gene. 1995 Jun 14;159(1):73-80. doi: 10.1016/0378-1119(94)00786-r. Gene. 1995. PMID: 7607575

8

A spacer region between the single chain antibody- and the CD3 zeta-chain domain of chimeric T cell receptor components is required for efficient ligand binding and signaling activity.

Moritz D, Groner B. Moritz D, et al. Among authors: groner b. Gene Ther. 1995 Oct;2(8):539-46. Gene Ther. 1995. PMID: 8593604

9

Transcriptional regulation and induction of apoptosis: implications for the use of monomeric p53 variants in gene therapy.

Merkle C, Fritsche M, Mundt M, Jähne R, Groner B. Merkle C, et al. Among authors: groner b. Gene Ther. 1998 Dec;5(12):1631-41. doi: 10.1038/sj.gt.3300773. Gene Ther. 1998. PMID: 10023442

10

Adoptive transfer of in vitro-targeted, activated T lymphocytes results in total tumor regression.

Altenschmidt U, Klundt E, Groner B. Altenschmidt U, et al. Among authors: groner b. J Immunol. 1997 Dec 1;159(11):5509-15. J Immunol. 1997. PMID: 9548491

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters